Imaging Modality Effects on the Multi-dimensional InfraRed Analysis (MIRA) Technology
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029977
(Re-definition of MIRA technology goals.)
The purpose of this study is to evaluate the effect of everyday practice modalities (mammography, US) on the MIRA technology.
Condition or disease
The objective of the current clinical study is to collect sufficient MIRA imaging data of subjects arriving for a routine screening mammography, before and after they undergo the mammography. This is in order to reach a conclusion whether the the firm breast compression involved in the mammography procedure affects the performance of the MIRA technology. At the current stage of the development of the device, the goal of this clinical trial is in no way to arrive at a statistical analysis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects arriving for a mammography or breast ultrasound
Age: 50 years and older
Subjects summoned for a routine screening mammography, ultrasound, diagnostic mammography or breast biopsy.
Subject who have signed an informed consent form.
Subjects who have had a mammography, ultrasound, and/or MRI examination performed on the day of the study, PRIOR to their FIRST imaging session with the RealImager.
Subjects who have undergone any type of breast surgery throughout the 6 weeks preceding the study.
Subjects who have had a breast biopsy performed throughout the 6 weeks preceding the study.
Subjects who have undergone a mastectomy.
Subjects who have undergone a lumpectomy.
Subjects who have a large scar (causing breast deformation).
Subjects who have previously undergone or are currently undergoing breast radiation therapy.
Subjects who have previously undergone or are currently undergoing chemotherapy.
Subjects with prior breast reduction surgery or breast augmentation surgery.